Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMSCs for Knee Osteoarthritis
NCT02805855Phase 1Completed
- Start
- Oct 2016
- Primary completion
- Sep 2023
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label trial of autologous adipose-derived mesenchymal stromal cells in osteoarthritis (OA) (4 arms). Primary endpoint: Number of subjects experiencing adverse events at 2 years. Started Oct 2016; status: completed.
02
Drugs
autologous adipose-derived mesenchymal stromal cells
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02805855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02805855.